Thomasville National Bank Bristol Myers Squibb CO Transaction History

Thomasville National Bank

  • $1.3 Billion
  • Q3 2024

A detailed history of Thomasville National Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Thomasville National Bank holds 19,747 shares of BMY stock, worth $1.05 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
19,747
Previous 20,977 5.86%
Holding current value
$1.05 Million
Previous $871,000 17.22%
% of portfolio
0.08%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024
SELL
$39.66 - $51.75 $48,781 - $63,652
-1,230 Reduced 5.86%
19,747 $1.02 Million
Q2 2024

Jul 10, 2024
SELL
$40.25 - $52.99 $68,988 - $90,824
-1,714 Reduced 7.55%
20,977 $871,000
Q1 2024

Apr 10, 2024
SELL
$47.98 - $54.4 $101,189 - $114,729
-2,109 Reduced 8.5%
22,691 $1.23 Million
Q4 2023

Jan 11, 2024
BUY
$48.48 - $57.85 $96 - $115
2 Added 0.01%
24,800 $1.27 Million
Q3 2023

Oct 10, 2023
SELL
$57.89 - $64.73 $37,686 - $42,139
-651 Reduced 2.56%
24,798 $1.44 Million
Q2 2023

Jul 10, 2023
SELL
$63.71 - $70.74 $23,700 - $26,315
-372 Reduced 1.44%
25,449 $1.63 Million
Q1 2023

Apr 10, 2023
SELL
$65.71 - $74.53 $119,066 - $135,048
-1,812 Reduced 6.56%
25,821 $1.79 Million
Q4 2022

Jan 10, 2023
SELL
$68.48 - $81.09 $5.15 Million - $6.1 Million
-75,184 Reduced 73.12%
27,633 $1.99 Million
Q3 2022

Oct 03, 2022
BUY
$0.13 - $76.84 $260 - $153,680
2,000 Added 1.98%
102,817 $7.31 Million
Q2 2022

Jul 28, 2022
SELL
$72.62 - $79.98 $47,420 - $52,226
-653 Reduced 0.64%
100,817 $7.76 Million
Q1 2022

Apr 14, 2022
BUY
$61.48 - $73.72 $67,259 - $80,649
1,094 Added 1.09%
101,470 $7.41 Million
Q4 2021

Jan 18, 2022
BUY
$53.63 - $62.52 $270,295 - $315,100
5,040 Added 5.29%
100,376 $6.26 Million
Q3 2021

Oct 04, 2021
BUY
$59.17 - $69.31 $159,581 - $186,929
2,697 Added 2.91%
95,336 $5.64 Million
Q2 2021

Jul 02, 2021
BUY
$61.91 - $67.42 $1 Million - $1.09 Million
16,209 Added 21.21%
92,639 $6.19 Million
Q1 2021

Apr 01, 2021
SELL
$59.34 - $66.74 $216,412 - $243,400
-3,647 Reduced 4.55%
76,430 $4.26 Million
Q4 2020

Jan 04, 2021
BUY
$57.74 - $65.43 $83,492 - $94,611
1,446 Added 1.84%
80,077 $4.97 Million
Q3 2020

Oct 01, 2020
SELL
$57.43 - $63.64 $59,727 - $66,185
-1,040 Reduced 1.31%
78,631 $4.74 Million
Q2 2020

Jul 01, 2020
BUY
$54.82 - $64.09 $3.34 Million - $3.9 Million
60,856 Added 323.44%
79,671 $4.69 Million
Q1 2020

Apr 02, 2020
SELL
$46.4 - $67.43 $2.31 Million - $3.36 Million
-49,761 Reduced 72.56%
18,815 $1.05 Million
Q4 2019

Jan 07, 2020
BUY
$49.21 - $64.19 $2.45 Million - $3.19 Million
49,761 Added 264.48%
68,576 $4.4 Million
Q3 2019

Oct 02, 2019
BUY
$42.77 - $50.71 $8,981 - $10,649
210 Added 1.13%
18,815 $954,000
Q2 2019

Jul 01, 2019
BUY
$44.62 - $49.34 $13,073 - $14,456
293 Added 1.6%
18,605 $843,000
Q1 2019

May 16, 2019
SELL
$45.12 - $53.8 $2,932 - $3,497
-65 Reduced 0.35%
18,312 $874,000
Q4 2018

Jan 17, 2019
SELL
$48.76 - $63.23 $24,672 - $31,994
-506 Reduced 2.68%
18,377 $955,000
Q3 2018

Oct 25, 2018
BUY
$55.19 - $62.25 $173,296 - $195,465
3,140 Added 19.95%
18,883 $1.17 Million
Q2 2018

Jul 11, 2018
SELL
$50.53 - $62.98 $43,001 - $53,595
-851 Reduced 5.13%
15,743 $871,000
Q1 2018

Apr 20, 2018
BUY
$59.92 - $68.98 $56,624 - $65,186
945 Added 6.04%
16,594 $1.05 Million
Q4 2017

Feb 05, 2018
SELL
$59.94 - $65.35 $251,688 - $274,404
-4,199 Reduced 21.16%
15,649 $959,000
Q3 2017

Nov 14, 2017
BUY
$55.23 - $63.74 $1.1 Million - $1.27 Million
19,848
19,848 $1.27 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Thomasville National Bank Portfolio

Follow Thomasville National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomasville National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Thomasville National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email